RA Capital Nexus Fund, L.P. Sells Vor Biopharma Inc. Common Stock

RA Capital Nexus Fund, L.P., a director and 10% stockholder of Vor Biopharma Inc., has filed a Form 144 indicating the intent to sell 24,916 shares of common stock. The shares were acquired through private financing transactions on 02/05/2020 and 06/30/2020. The aggregate market value of the shares to be sold is approximately $724,058.96. Additionally, the fund recently sold 8,430 shares on 10/15/2025, generating gross proceeds of $257,585.39. The sale is expected to occur on or around 10/16/2025, with BTIG, LLC acting as the broker.